WATKINS FRANK T 4
4 · Shockwave Medical, Inc. · Filed Jan 10, 2024
Insider Transaction Report
Form 4
WATKINS FRANK T
Director
Transactions
- Sale
Common Stock
2024-01-08$200.17/sh−1,100$220,187→ 4,532 total - Exercise/Conversion
Stock Option
2024-01-08−2,000→ 88,313 totalExercise: $3.42Exp: 2027-05-09→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2024-01-08$3.42/sh+2,000$6,832→ 6,532 total - Sale
Common Stock
2024-01-08$197.94/sh−700$138,558→ 5,632 total - Sale
Common Stock
2024-01-08$196.15/sh−200$39,230→ 6,332 total
Footnotes (5)
- [F1]All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 9/5/2023.
- [F2]All reported securities were sold at a price of $196.15.
- [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $197.85 to $198.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $199.78 to $200.28. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F5]Fully vested.